Last reviewed · How we verify
Bimanol (deanol)
Bimanol (generic name: deanol) is a deanol drug. It is currently in unknown development.
Bimanol increases levels of neurotransmitters such as dopamine and norepinephrine in the brain.
Bimanol is a small molecule with the chemical formula (CH3)2NCH2CH2OH, also known as dimethylethanolamine. It is used in skin care products to improve skin tone and is also taken orally as a nootropic.
At a glance
| Generic name | deanol |
|---|---|
| Drug class | deanol |
| Target | Creatine transporter, High affinity choline transporter 1 |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Think of neurotransmitters like messengers that help different parts of the brain talk to each other. Bimanol helps increase the amount of these messengers, which can improve communication between brain cells and potentially treat certain conditions. This can lead to improved mood, focus, and other cognitive functions.
Approved indications
Common side effects
Key clinical trials
- Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-Aging (PHASE2)
- The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (PHASE2)
- The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (PHASE1,PHASE2)
- The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bimanol CI brief — competitive landscape report
- Bimanol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Bimanol
What is Bimanol?
How does Bimanol work?
What is the generic name of Bimanol?
What drug class is Bimanol in?
What development phase is Bimanol in?
What does Bimanol target?
Related
- Drug class: All deanol drugs
- Target: All drugs targeting Creatine transporter, High affinity choline transporter 1
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing